Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
- 4 October 2009
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 50 (11) , 1875-1878
Abstract
(2009). Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leukemia & Lymphoma: Vol. 50, No. 11, pp. 1875-1878.Keywords
This publication has 15 references indexed in Scilit:
- CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expressionHaematologica, 2009
- Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)Experimental Hematology, 2009
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOPBlood, 2008
- Epigenetic regulation of MHC-II and CIITA genesTrends in Immunology, 2006
- Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalBlood, 2006
- Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletionsBlood, 2005
- Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling ProjectBlood, 2004
- Kinetics of a Gamma Interferon Response: Expression and Assembly of CIITA Promoter IV and Inhibition by MethylationMolecular and Cellular Biology, 2002
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.Journal of Experimental Medicine, 1983